Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| Correlazione In Vitro-In Vivo× | Cinetica di Michaelis-Menten× | |
|---|---|---|
| Campo | Farmacologia | Farmacologia |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 1995 | 1913 |
| Ideatore≠ | Gordon Amidon | Leonor Michaelis and Maud Menten |
| Tipo≠ | bioavailability prediction | mechanistic model |
| Fonte seminale≠ | Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research, 12(3), 413-420. DOI ↗ | Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗ |
| Alias≠ | IVIVC | MM kinetics, Michaelis constant, Vmax |
| Correlati≠ | 3 | 2 |
| Sintesi≠ | IVIVC is a mathematical relationship between in vitro and in vivo properties of a drug, developed to predict oral bioavailability from dissolution data. Introduced by Amidon and colleagues in the 1995 Biopharmaceutics Classification System, it bridges laboratory measurements and clinical outcomes to streamline drug development. | Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics. |
| ScholarGateInsieme di dati ↗ |
|
|